OxohydrastinineCAS# 552-29-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 552-29-4 | SDF | Download SDF |
PubChem ID | 160522 | Appearance | Powder |
Formula | C11H11NO3 | M.Wt | 205.2 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 6-methyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-5-one | ||
SMILES | CN1CCC2=CC3=C(C=C2C1=O)OCO3 | ||
Standard InChIKey | WIUVXEAALLSOQN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H11NO3/c1-12-3-2-7-4-9-10(15-6-14-9)5-8(7)11(12)13/h4-5H,2-3,6H2,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Oxohydrastinine shows certain antibacterial activity in vitro. |
Targets | Antifection |
Oxohydrastinine Dilution Calculator
Oxohydrastinine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.8733 mL | 24.3665 mL | 48.7329 mL | 97.4659 mL | 121.8324 mL |
5 mM | 0.9747 mL | 4.8733 mL | 9.7466 mL | 19.4932 mL | 24.3665 mL |
10 mM | 0.4873 mL | 2.4366 mL | 4.8733 mL | 9.7466 mL | 12.1832 mL |
50 mM | 0.0975 mL | 0.4873 mL | 0.9747 mL | 1.9493 mL | 2.4366 mL |
100 mM | 0.0487 mL | 0.2437 mL | 0.4873 mL | 0.9747 mL | 1.2183 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Kaempferol 3-sophoroside-7-glucoside
Catalog No.:BCN7825
CAS No.:55136-76-0
- (S)-3-Carboxy-4-hydroxyphenylglycine
Catalog No.:BCC6607
CAS No.:55136-48-6
- 4beta-Carboxy-19-nortotarol
Catalog No.:BCN4065
CAS No.:55102-39-1
- 2'-Aminoacetophenone
Catalog No.:BCN1746
CAS No.:551-93-9
- Dimetridazole
Catalog No.:BCC8944
CAS No.:551-92-8
- Supinine
Catalog No.:BCN1952
CAS No.:551-58-6
- Viridiflorine
Catalog No.:BCN2045
CAS No.:551-57-5
- 6-Aminopenicillanic acid
Catalog No.:BCC8765
CAS No.:551-16-6
- Liquiritin
Catalog No.:BCN5944
CAS No.:551-15-5
- 3-Butylidenephthalide
Catalog No.:BCN6345
CAS No.:551-08-6
- EVP-6124
Catalog No.:BCC1566
CAS No.:550999-75-2
- EVP-6124 hydrochloride
Catalog No.:BCC1567
CAS No.:550999-74-1
- Paeonol
Catalog No.:BCN5738
CAS No.:552-41-0
- Isorhoifolin
Catalog No.:BCN5739
CAS No.:552-57-8
- Eriodictyol
Catalog No.:BCN1209
CAS No.:552-58-9
- Prunetin
Catalog No.:BCN2335
CAS No.:552-59-0
- Daidzin
Catalog No.:BCN5891
CAS No.:552-66-9
- Sasapyrine
Catalog No.:BCC4714
CAS No.:552-94-3
- Dexamethasone Sodium Phosphate
Catalog No.:BCC4557
CAS No.:55203-24-2
- AP 18
Catalog No.:BCC7634
CAS No.:55224-94-7
- Rolapitant
Catalog No.:BCC6441
CAS No.:552292-08-7
- Vallesiachotamine
Catalog No.:BCN3548
CAS No.:5523-37-5
- T16Ainh - A01
Catalog No.:BCC6220
CAS No.:552309-42-9
- A-443654
Catalog No.:BCC1321
CAS No.:552325-16-3
Application of chromatography technology in the separation of active alkaloids from Hypecoum leptocarpum and their inhibitory effect on fatty acid synthase.[Pubmed:26544947]
J Sep Sci. 2015 Dec;38(23):4063-70.
A method that involved the combination of pH-zone-refining counter-current chromatography and semipreparative reversed-phase liquid chromatography has been established for the preparative separation of alkaloids from Hypecoum leptocarpum. From 1.2 g of crude sample, 31 mg N-feruloyltyramine, 27 mg Oxohydrastinine, 47 mg hydroprotopine, 25 mg leptopidine, and 18 mg hypecocarpine have been obtained. The structure of the new compound, hypecocarpine, is confirmed based on the analysis of spectroscopic data, including NMR, UV, and IR spectroscopy and positive electrospray ionization mass spectrometry. The known chemical structures were characterized on the basis of (1) H and (13) C NMR spectroscopy. The purities of the five alkaloids are all over 92.7% as determined by high-performance liquid chromatography. The alkaloids' cytotoxicity in breast cancer cells is assessed by using a Cell Counting Kit assay and their inhibitory effect on fatty acid synthase expression is assessed by a Western blot assay. These results suggest that leptopidine could suppress growth and induce cytotoxicity in breast cancer cells and that the cytotoxicity of leptopidine may be related to its inhibitory effect on fatty acid synthase expression.
One Step to Separate Five Alkaloids from Hypecoum leptocarpum by High-Speed Counter-Current Chromatography.[Pubmed:26499120]
J Chromatogr Sci. 2016 Mar;54(3):466-71.
High-speed counter-current chromatography (CCC) was firstly and successfully applied for the preparative separation and purification of alkaloids from crude extract of Hypecoum leptocarpum. After the measurement of partition coefficient of five target alkaloids in the two-phase solvent systems, the CCC was performed well with a two-phase solvent system composed of tetrachloromethane-chloroform-methanol-0.1 M HCl at a volume ratio of 1.5 : 2.5 : 3 : 2 (V/V/V/V). The upper phase was used as the stationary phase, and the lower phase was used as the mobile phase. From 120 mg crude extract, 5 mg leptopidine, 32 mg Oxohydrastinine, 27 mg (-)-N-methylanadine, 7 mg N-feruloyltyramine and 3 mg hypecoleptopine could be successfully separated. The amides alkaloid, N-feruloyltyramine, was firstly separated from H. leptocarpum. High-performance liquid chromatography analysis showed that the purity of each of the five target alkaloids was over 92%. Their chemical structures were confirmed by (1)H-NMR and (13)C-NMR data.